Athersys shares rebound somewhat since falling by two-thirds on clinical trial results By: Cleveland Business Journal via Business Journals June 17, 2022 at 14:55 PM EDT Athersys plans to ask shareholders to approve a reverse stock split of its shares. Read More >> Related Stocks: Harbor Disruptive Innovation ETF
